tiprankstipranks
BICO Group AB Class B (CLLKF)
OTHER OTC:CLLKF
Holding CLLKF?
Track your performance easily

BICO Group AB Class B (CLLKF) Stock Price & Analysis

34 Followers

CLLKF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%1.56%96.64%
Insiders
1.56% Other Institutional Investors
96.64% Public Companies and
Individual Investors

CLLKF FAQ

What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was $2.84 and its highest was $7.32 in the past 12 months.
    What is BICO Group AB Class B’s market cap?
    Currently, no data Available
    When is BICO Group AB Class B’s upcoming earnings report date?
    BICO Group AB Class B’s upcoming earnings report date is Feb 19, 2025 which is in 84 days.
      How were BICO Group AB Class B’s earnings last quarter?
      BICO Group AB Class B released its earnings results on Nov 26, 2024. The company reported -$0.331 earnings per share for the quarter, missing the consensus estimate of -$0.04 by -$0.291.
        Is BICO Group AB Class B overvalued?
        According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BICO Group AB Class B pay dividends?
          BICO Group AB Class B does not currently pay dividends.
          What is BICO Group AB Class B’s EPS estimate?
          BICO Group AB Class B’s EPS estimate is -$0.02.
            How many shares outstanding does BICO Group AB Class B have?
            BICO Group AB Class B has 69,074,900 shares outstanding.
              What happened to BICO Group AB Class B’s price movement after its last earnings report?
              BICO Group AB Class B reported an EPS of -$0.331 in its last earnings report, missing expectations of -$0.04. Following the earnings report the stock price went down -17.857%.
                Which hedge fund is a major shareholder of BICO Group AB Class B?
                Currently, no hedge funds are holding shares in CLLKF
                ---

                BICO Group AB Class B Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -44.42%
                12-Months-Change

                Fundamentals

                Return on Equity
                -23.63%
                Trailing 12-Months
                Asset Growth
                -36.26%
                Trailing 12-Months

                Company Description

                BICO Group AB Class B

                CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments.
                ---

                CLLKF Company Deck

                ---

                CLLKF Earnings Call

                Q3 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Quantum-Si
                10x Genomics
                Pacific Biosciences
                Illumina
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis